Low mortality, stroke seen with newest Edwards TAVR system: study

(Reuters) - Researchers on Sunday presented trial data showing very low mortality and stroke rates using the third generation version of Edwards Lifesciences Corp's non-invasive heart valve replacement system that could help support its U.S. approval.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news